HBCR‐TAVR 2019.

Study name	Impact of home‐based cardiac rehabilitation on outcomes after TAVR (HBCR‐TAVR)
Methods	Parallel‐assignment RCT
Participants	Chinese patients after transcatheter aortic valve replacement (TAVR)
Interventions	Placebo comparator: control group: routine care Experimental: intervention group: home‐based cardiac rehabilitation
Outcomes	Primary outcome measures 6‐minute walk test [Time Frame: 6 weeks, total distance walked in meters during 6 minutes] Secondary outcome measures Number of participants to die [Time Frame: 6 weeks, 12 months, number of participants who die during the study due to cardiovascular or non‐cardiovascular causes] Number of participants re‐hospitalised [Time Frame: 6 weeks, 12 months, number of participants re‐hospitalised during the study] Number of participants completing home‐based cardiac rehabilitation [Time Frame: 6 weeks, number of participants completing home‐based cardiac rehabilitation] Cardiac function [Time Frame: 12 months, ejection fraction estimated by echocardiography] Aortic valve function [Time Frame: 12 months, aortic valve function estimated by echocardiography] Number of participants injured [Time Frame: 6 weeks, number of participants injured or dying during the course of home‐based cardiac rehabilitation] Time spent performing activities [Time Frame: 6 weeks, 12 months, number of minutes in a typical week that participants spent performing activities] 6‐minute walk test [Time Frame: 12 months, total distance walked in meters during 6 minutes]
Starting date	9 May 2020
Contact information	Xiaoya Wang, 15715702712 wxyonce@zju.edu.cn
Notes	Estimated enrolment: 300 participants. Estimated study completion date: 31 December 2023 Locations: Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China, 310000